Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Sunvozertinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 229,794Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6DIZAL JIANGSU

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    DIZAL JIANGSU

    SUNVOZERTINIB

    arrow
    ESCRS
    Not Confirmed

    DIZAL JIANGSU

    Country
    arrow
    ESCRS
    Not Confirmed

    Patent Expiration Date : 2039-01-28

    SUNVOZERTINIB

    US Patent Number : 11504375

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 219839

    Patent Use Code : U-3220

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2039-01-28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    DIZAL JIANGSU

    SUNVOZERTINIB

    arrow
    ESCRS
    Not Confirmed

    DIZAL JIANGSU

    Country
    arrow
    ESCRS
    Not Confirmed

    Patent Expiration Date : 2039-01-28

    SUNVOZERTINIB

    US Patent Number : 11504375

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 219839

    Patent Use Code : U-3220

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2039-01-28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    DIZAL JIANGSU

    SUNVOZERTINIB

    arrow
    ESCRS
    Not Confirmed

    DIZAL JIANGSU

    Country
    arrow
    ESCRS
    Not Confirmed

    Patent Expiration Date : 2039-01-28

    SUNVOZERTINIB

    US Patent Number : 11896597

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 219839

    Patent Use Code : U-3220

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2039-01-28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    DIZAL JIANGSU

    SUNVOZERTINIB

    arrow
    ESCRS
    Not Confirmed

    DIZAL JIANGSU

    Country
    arrow
    ESCRS
    Not Confirmed

    Patent Expiration Date : 2039-01-28

    SUNVOZERTINIB

    US Patent Number : 11896597

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 219839

    Patent Use Code : U-3220

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2039-01-28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    DIZAL JIANGSU

    SUNVOZERTINIB

    arrow
    ESCRS
    Not Confirmed

    DIZAL JIANGSU

    Country
    arrow
    ESCRS
    Not Confirmed

    Patent Expiration Date : 2039-01-28

    SUNVOZERTINIB

    US Patent Number : 11007198

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 219839

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2039-01-28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    DIZAL JIANGSU

    SUNVOZERTINIB

    arrow
    ESCRS
    Not Confirmed

    DIZAL JIANGSU

    Country
    arrow
    ESCRS
    Not Confirmed

    Patent Expiration Date : 2039-01-28

    SUNVOZERTINIB

    US Patent Number : 11007198

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 219839

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2039-01-28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF